What are Charles River Laboratories's total assets?

Charles River Laboratories (CRL) holds $7.7B in total assets, up 1.9% year over year.

How much debt does Charles River Laboratories have?

Charles River Laboratories carries $3.1B in total debt against $2.9B of shareholders' equity, a debt-to-equity ratio of 1.05.

How much cash does Charles River Laboratories have?

Charles River Laboratories holds $198.2M in cash and equivalents.

Can Charles River Laboratories cover its short-term obligations?

Its current ratio is 1.36 — current assets exceed current liabilities.

Where does Charles River Laboratories's balance sheet data come from?

Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Charles River Laboratories CRL Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$216M+5.1%	$205.57M-27.7%	$284.48M+17.9%	$241.21M-2.1%
Restricted cash	$1.56M—	——	$5.8M-6.3%	$6.19M+53.9%
Accounts receivable, net	$719.32M-2.7%	$739.22M-8.3%	$806.1M+5.6%	$763.67M+17.5%
Inventories	$299.1M+7.4%	$278.54M-26.7%	$380.26M+48.6%	$255.81M+28.5%
Raw materials	$40.96M-4.8%	$43.04M+1.8%	$42.3M+8.8%	$38.89M+17.4%
Work in process	$88.74M+71.4%	$51.79M-13.3%	$59.73M+23.5%	$48.37M+20.1%
Finished goods	$169.4M-7.8%	$183.72M-34.0%	$278.24M+65.1%	$168.55M+34.0%
Prepaid expenses and other current assets	$129.21M+22.1%	$105.8M+26.9%	$83.38M-22.5%	$107.58M+10.6%
Income taxes receivable	$119.9M+44.5%	$83M+39.0%	$59.72M-32.6%	$88.55M+4.5%
Assets held for sale	$21.22M—	——	——	——
Total current assets	$1.45B+3.1%	$1.4B-12.8%	$1.61B+11.8%	$1.44B+12.9%
Property and equipment, net	$1.66B+3.2%	$1.6B-2.2%	$1.64B+11.9%	$1.47B+13.5%
Accumulated depreciation	$1.54B+5.7%	$1.45B+8.9%	$1.34B+82.4%	$732.12M+19.8%
Operating lease right-of-use assets	$361.42M-12.4%	$412.49M+4.7%	$394.03M+0.6%	$391.76M+33.7%
Goodwill	$2.76B-2.9%	$2.85B-8.0%	$3.1B+8.6%	$2.85B+5.1%
Intangible assets, net	$340M-53.0%	$723.4M-16.3%	$864.05M-9.5%	$955.28M-10.0%
Deferred tax assets	$95.2M-11.0%	$106.96M-44.1%	$191.35M-11.2%	$215.58M-10.1%
Other non-current assets	$31.18M-88.8%	$278.23M-10.1%	$309.38M+109%	$148.28M+260%
Equity method investments	$206.97M-5.2%	$218.35M-10.4%	$243.81M-21.8%	$311.6M+54.8%
Total assets	$7.14B-5.2%	$7.53B-8.1%	$8.2B+7.8%	$7.6B+8.2%
Accounts payable	$148.8M+6.0%	$140.34M-16.9%	$168.94M-18.0%	$205.92M+3.9%
Accrued expenses	$268.85M+49.8%	$179.42M-15.9%	$213.29M+8.2%	$197.08M-19.9%
Deferred revenue	$210.42M-15.3%	$248.32M+2.7%	$241.82M-8.5%	$264.26M+20.3%
Current portion of long-term debt	$166K+7.1%	$155K-95.1%	$3.17M+135%	$1.35M+1,234%
Finance Lease Liability, Current	$3.23M+16.4%	$2.77M+15.7%	$2.4M+2.9%	$2.33M-13.5%
Liabilities held for sale	$0—	——	——	——
Contract liabilities	$45.63M+33.1%	$34.29M+10.9%	$30.92M—	——
Income taxes payable	$39.02M+22.4%	$31.87M-17.9%	$38.82M-2.6%	$39.85M+52.3%
Accrued interest	——	——	——	——
Total current liabilities	$1.12B+12.7%	$994.1M-5.8%	$1.06B-3.3%	$1.09B+5.7%
Long-term debt	$2.14B-4.6%	$2.24B-15.4%	$2.65B-2.2%	$2.71B+1.7%
Operating lease liabilities, non-current	$434.05M-10.3%	$483.79M+15.4%	$419.23M+7.6%	$389.75M+54.1%
Finance Lease Liabilities (Total)	$27.88M-2.0%	$28.44M-0.4%	$28.55M-6.8%	$30.65M+12.6%
Finance lease liabilities	$24.65M-4.0%	$25.67M-1.8%	$26.15M-7.6%	$28.32M+15.4%
Other non-current liabilities	$138.3M-29.2%	$195.21M-12.5%	$223.19M+27.7%	$174.82M-28.0%
Total liabilities	$30M-99.3%	$4.02B-11.4%	$4.54B-0.9%	$4.58B+3.3%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	120M+23,383%	511K-0.4%	513K+0.8%	509K+0.8%
Additional paid-in capital	$1.95B-1.0%	$1.97B+3.2%	$1.91B+5.6%	$1.8B+5.0%
Retained earnings	$1.39B-23.4%	$1.81B-4.0%	$1.89B+31.7%	$1.43B+46.1%
Accumulated other comprehensive income (loss)	-$171.78M+45.9%	-$317.35M-61.6%	-$196.43M+25.0%	-$262.06M-59.1%
Treasury stock	$0—	$0—	$0—	$0—
Redeemable noncontrolling interests	$41.26M+0.3%	$41.13M-27.5%	$56.72M+33.7%	$42.43M-20.0%
Noncontrolling interests	$5.3M-2.7%	$5.45M+1.0%	$5.39M+12.7%	$4.79M+15.0%
Total stockholders' equity	$3.16B-8.6%	$3.46B-3.8%	$3.6B+20.9%	$2.98B+17.4%
Total liabilities and stockholders' equity	$7.14B-5.2%	$7.53B-8.1%	$8.2B+7.8%	$7.6B+8.2%
Allowance for Doubtful Accounts	$10.46M-42.8%	$18.3M-28.9%	$25.72M+128%	$11.28M+57.1%
Allowance for Doubtful Accounts Receivable (Current)	$10.46M-42.8%	$18.3M-28.9%	$25.72M+128%	$11.28M+57.1%
Finished goods	$169.4M-7.8%	$183.72M-34.0%	$278.24M+65.1%	$168.55M+34.0%
Materials and supplies	$40.96M-4.8%	$43.04M+1.8%	$42.3M+8.8%	$38.89M+17.4%
Unbilled Revenue	$200.59M-5.4%	$212M-7.0%	$228M+11.8%	$204M+27.0%
Deferred Tax Assets and Other Non-Current Assets	$293.19M+5.4%	$278.23M-10.1%	$309.38M+109%	$148.28M+693%
Finite Lived Intangible Assets - Gross	$1.5B-11.7%	$1.7B-1.9%	$1.73B+2.5%	$1.69B+0.9%
Net Investment in Lease	$361.42M-12.4%	$412.49M+4.7%	$394.03M+0.6%	$391.76M+33.7%
Deferred tax assets	$67.33M+59.6%	$42.18M+4.7%	$40.28M-2.4%	$41.26M+2.6%
Intangible assets — net	$340M-53.0%	$723.4M-16.3%	$864.05M-9.5%	$955.28M-10.0%
Operating lease right-of-use assets	$361.42M-12.4%	$412.49M+4.7%	$394.03M+0.6%	$391.76M+33.7%
Other non-current assets	$293.19M+5.4%	$278.23M-10.1%	$309.38M+109%	$148.28M-2.1%
Property, plant and equipment, net	$1.66B+3.2%	$1.6B-2.2%	$1.64B+11.9%	$1.47B+13.5%
Property, plant and equipment at cost	$3.19B+4.4%	$3.06B—	——	——
Operating Lease Right-of-Use Assets in Other Assets	$361.42M-12.4%	$412.49M+4.7%	$394.03M+0.6%	$391.76M+33.7%
Software and Technology Licenses, Net	$293.19M+5.4%	$278.23M-10.1%	$309.38M+109%	$148.28M-2.1%
Accrued Manufacturing Costs	$268.85M+49.8%	$179.42M-15.9%	$213.29M+8.2%	$197.08M-19.9%
Accrued Progress Collections and Price Adjustments	$45.63M+33.1%	$34.29M+10.9%	$30.92M—	——
Other Commercial Liabilities	$270.09M+16.4%	$232.01M+1.8%	$227.83M+3.7%	$219.76M-4.0%
Commercial Paper Outstanding	$22M—	——	——	——
Accrued Income Taxes, Current	$39.02M+22.4%	$31.87M-17.9%	$38.82M-2.6%	$39.85M+52.3%
Accrued Liabilities, Current	$270.09M+16.4%	$232.01M+1.8%	$227.83M+3.7%	$219.76M-4.0%
Compensation and benefits	$268.85M+49.8%	$179.42M-15.9%	$213.29M+8.2%	$197.08M-19.9%
Other accrued liabilities	$222.16M+14.5%	$194.01M-4.5%	$203.21M-0.7%	$204.58M+45.7%
Current Portion of Long-Term Debt and Finance Lease Obligations	$3.39M+15.9%	$2.93M-47.4%	$5.57M+51.5%	$3.68M+31.6%
Restructuring Reserve	$23.01M-9.2%	$25.34M+402%	$5.05M+288%	$1.3M—
Short-Term Debt - Weighted-Average Interest Rate	4.1%-0.4%	4.5%-0.4%	4.9%+0.3%	4.6%+1.8%
Contract Liabilities, Non-Current	$45.63M+33.1%	$34.29M+10.9%	$30.92M—	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	-$12.47M+21.4%	-$15.86M-8.3%	-$14.65M+21.3%	-$18.62M+17.8%
Defined Benefit Pension Plan Liabilities (Non-Current)	$68.44M—	——	——	——
Long-Term Debt and Finance Lease Obligations	$2.14B-4.6%	$2.24B-15.4%	$2.65B-2.2%	$2.71B+1.7%
Deferred revenue, net of current portion	$45.63M+33.1%	$34.29M+10.9%	$30.92M—	——
Total debt	$2.66B-5.4%	$2.81B-11.0%	$3.15B-0.7%	$3.18B+6.7%
Unrecognized Tax Benefits	——	——	——	——
Unrecognized Tax Benefits - Impacting Effective Tax Rate	——	——	——	——
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued	——	——	——	——
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	49.2M-3.8%	51.1M-0.4%	51.3M+0.8%	50.9M+0.9%
Convertible Preferred Stock Authorized Shares	20M0.0%	20M0.0%	20M0.0%	20M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Additional paid-in capital	$1.95B-1.0%	$1.97B+3.2%	$1.91B+5.6%	$1.8B+5.0%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$492K-3.7%	$511K-0.4%	$513K+0.8%	$509K+0.8%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Deferred Revenue Timing Percentage	——	——	——	——
Income taxes payable – long-term	$15.34M—	——	——	——
Accounts Receivable, Allowance for Credit Loss	$10.46M-42.8%	$18.3M-28.9%	$25.72M+128%	$11.28M—
Allowance for doubtful accounts	$10.46M-42.8%	$18.3M-28.9%	$25.72M+128%	$11.28M+57.1%
Bearer biological assets	$135.65M—	——	——	——
Insurance contracts	$58.43M—	——	——	——
Cash surrender value of life insurance policies	$66.32M—	——	——	——
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$120M0.0%	$120M0.0%	$120M0.0%	$120M0.0%
Common stock, shares issued (in shares)	$49.22M-3.8%	$51.14M-0.4%	$51.34M+0.8%	$50.94M+0.9%
Common Stock, Shares, Outstanding	$49.22M-3.8%	$51.14M-0.4%	$51.34M+0.8%	$50.94M+0.9%
Contract assets	$200.59M-5.4%	$212M-7.0%	$228M+11.8%	$204M+27.0%
Contract with Customer, Liability	$256M-9.5%	$283M+3.7%	$273M-5.9%	$290M—
Customer contract deposits (included in Other current liabilities)	$106.6M+19.2%	$89.45M+4.5%	$85.55M-6.6%	$91.64M+54.0%
Unpaid advanced client billings	$43M+13.2%	$38M-7.3%	$41M-24.1%	$54M+50.0%
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	-$12.47M+21.4%	-$15.86M-8.3%	-$14.65M+21.3%	-$18.62M+17.8%
Weighted Average Interest Rate (as a percent)	$0.04-9.6%	$0.04-9.1%	$0.05+7.6%	$0.05+64.7%
Deferred income taxes	$95.2M-11.0%	$106.96M-44.1%	$191.35M-11.2%	$215.58M-10.1%
Future pension and postretirement benefit obligations	$68.44M—	——	——	——
Cash classified as held for sale in Other assets	——	——	——	——
Equity method investments (Note 11)	$206.97M-5.2%	$218.35M-10.4%	$243.81M-21.8%	$311.6M+54.8%
Current maturities of long-term debt	$3.23M+16.4%	$2.77M+15.7%	$2.4M+2.9%	$2.33M-13.5%
Finite-Lived Intangible Assets, Accumulated Amortization	$1.16B+18.9%	$973.45M+12.5%	$865.51M+18.2%	$732.12M+19.8%
Gross Carrying Amount	$1.5B-11.7%	$1.7B-1.9%	$1.73B+2.5%	$1.69B+0.9%
Goodwill, Gross	$2.76B—	——	——	$2.85B+5.1%
Letters of Credit Outstanding, Amount	$22M—	——	——	——
Liabilities of discontinued operations (Note 2)	$0—	——	——	——
Long-Term Debt and Lease Obligation	$2.14B-4.6%	$2.24B-15.4%	$2.65B-2.2%	$2.71B+1.7%
Less: current maturities	$3.39M+15.9%	$2.93M-47.4%	$5.57M+51.5%	$3.68M+31.6%
Long-Term Debt And Lease Obligation, Net Of Current Portion	$2.15B-4.8%	$2.26B-15.2%	$2.66B-2.4%	$2.73B+1.5%
Long-Term Debt, Gross And Lease Obligation	$2.15B-4.7%	$2.26B-15.3%	$2.67B-2.3%	$2.73B+1.5%
Noncontrolling interests in subsidiaries	$5.3M-2.7%	$5.45M+1.0%	$5.39M+12.7%	$4.79M+15.0%
Long-Lived Assets	$1.66B+3.2%	$1.6B-2.2%	$1.64B—	——
Other	$8.89M—	——	——	——
Long-term pension assets	$37.26M—	——	——	——
Preferred Stock, Par or Stated Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Preferred Stock, Shares Authorized	$20M0.0%	$20M0.0%	$20M0.0%	$20M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Prepaid expenses	$96.11M-6.9%	$103.21M+17.4%	$87.88M-1.6%	$89.34M-4.5%
Redeemable noncontrolling interests in subsidiaries	$41.26M+0.3%	$41.13M-27.5%	$56.72M+33.7%	$42.43M-20.0%
Restructuring Reserve	$23.01M-9.2%	$25.34M+402%	$5.05M+288%	$1.3M—
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	——	——	——
Client receivables	$518.73M-1.7%	$527.71M-8.7%	$578.08M+3.3%	$559.41M+14.3%
Treasury stock, shares (in shares)	$0—	$0—	$0—	$0—
Unrecognized tax benefits	——	——	——	——
Interest accrued	——	——	——	——
Amount that if recognized, would affect the effective tax rate or regulatory liability	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Charles River Laboratories.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Charles River Laboratories's total assets?: Charles River Laboratories (CRL) holds $7.7B in total assets, up 1.9% year over year.
How much debt does Charles River Laboratories have?: Charles River Laboratories carries $3.1B in total debt against $2.9B of shareholders' equity, a debt-to-equity ratio of 1.05.
How much cash does Charles River Laboratories have?: Charles River Laboratories holds $198.2M in cash and equivalents.
Can Charles River Laboratories cover its short-term obligations?: Its current ratio is 1.36 — current assets exceed current liabilities.
Where does Charles River Laboratories's balance sheet data come from?: Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.